ALQA -26% on “strategic alternatives” PR: https://globenewswire.com/news-release/2017/11/09/1178485/0/en/Alliqua-BioMedical-Inc-Engages-Cowen-to-Assist-in-Evaluating-Potential-Strategic-Alternatives.html Normally, these kinds of PRs make the share price go up.